pSivida Corp. Share Price Nasdaq

Stocks

09/16/09	PSivida : Primary Endpoint Met in pSivida's Utilization Study of New Medidur™ Inserter with Smaller Diameter Needle	PU
14/16/14	PSivida : Investigator-Sponsored Phase 2 Study Results Show pSivida's Medidur® Fully Controlled Uveitis for Two Years with No Recurrence of Disease While Visual Acuity Continued to Improve	PU
02/16/02	PSivida : Medidur for Posterior Uveitis Granted Orphan Drug Designation in Europe	PU
28/15/28	PSivida : Announces NDA for Medidur™ Now Planned Using Six-Month Efficacy Data from Both Phase III Trials; FDA Concurs	BU
14/15/14	PSivida : CEO to Present at Ladenburg Thalmann 2015 Healthcare Conference September 29, 2015	BU

1 day

-0.87%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PSIVIDA CORP.	-0.87%	-2.40%	-	-	0
ARGENX SE	-0.38%	-3.44%	+71.35%	+128.83%	5.67TCr
WUXI APPTEC CO., LTD.	+4.91%	-3.30%	+71.97%	+92.14%	5.13TCr
INSMED INCORPORATED	+1.48%	+5.97%	+22.59%	+495.47%	2.53TCr
BIONTECH SE	-0.59%	-4.68%	-16.82%	-12.99%	2.37TCr
WUXI BIOLOGICS (CAYMAN) INC.	+3.93%	+3.35%	+43.09%	-1.96%	1.87TCr
GENMAB A/S	+2.01%	+2.99%	+40.72%	-24.93%	1.77TCr
PHARMAESSENTIA CORPORATION	-6.84%	+2.18%	+203.03%	+348.11%	1.77TCr
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-0.92%	+1.58%	+35.79%	-	1.43TCr
EXELIXIS, INC.	+1.76%	+2.24%	+29.57%	+195.70%	1.41TCr
Average	+0.45%	+2.46%	+55.70%	+152.55%	2.66TCr
Weighted average by Cap.	+1.06%	+0.75%	+58.31%	+145.18%

Employees

Sector